Navigation Links
Aspirin Might Counter Side Effects of Cox-2 Painkillers

After the failure of Vioxx, pain killer which was found to cause the death of Robert C. Ernst on May 2001 after taking Vioxx. Merck Pharma the manufacturers of Vioxx were asked by the Texas Jury to pay $253.5 million as compensation // to Mrs. Ernst. Over 5 years, about 20 million people worldwide took Vioxx before Merck stopped selling the drug in September 2004, after a clinical trial found irrefutable evidence that Vioxx had heart risks compared with a placebo.

Due to the high toxic and side effects of pain killers like Vioxx, the researchers were in search of pain killers with no toxic effects and they found that the Age old still world wide used Aspirin was found to have no toxicity in addition it was found to decrease the incidence of heart attacks. The study was conducted by Dr. Thomas Coffman, Chief of Nephrology at Duke University. The findings of the research which was published in Cell metabolism has shown that the painkillers like Vioxx are strong Cox-2 inhibitors which interferes with the chemical pathways that causes pain.

v Though Cox-2 inhibitors have good effect in reducing pain, they may cause high blood pressure and severe cardiovascular problems. These drugs inhibit both the hormones responsible for both widening and narrowing of the blood vessels and this causes blood to form dangerous clots. Contrast to Cox-2 inhibitors, aspirin helps in blood thinning which is good for blood circulation. Though the research success as occurred in genetically modified mice model the scientists as to go for a clinical trial in order to test the efficacy of the drug in humans. The cardiovascular protection of the aspirin drug has to be tested in Cox-2 inhibitor drug users. The recruit for the study has to be taking Cox-2 drugs for some time and they should be given aspirin and compared with the placebo and Cox-2 drug user groups.


'"/>




Page: 1

Related medicine news :

1. What happens when Asthmatics consume Aspirin?
2. Aspirin reduces deaths
3. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
4. Aspirin - a drug after one’s own hear
5. Aspirin deflated
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Night Time Aspirin Regimen Found to Reduce Blood Pressure
8. Aspirin Lowers Leukemia Risk
9. Aspirin usage linked with pancreatic cancer
10. Aspirin Found To Reduce The Risk Of Colon Cancer
11. Aspirin Induced Asthma , A Little-Known Inducer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... ... March 29, 2017 , ... Based on research from Guardian’s ... face in trying to balance both short-term and long-term benefits demands. Are ... the growing complexity, companies are finding that the short-term strategies used to control ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is pleased ... Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with ... S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... TEL AVIV, Israel , March 29, 2017 ... license agreement in which Exeltis will obtain exclusive marketing rights for ... ... is an age-appropriate drug targeted to treat sleep disorders in children ... to be the first sleep medication approved for children. ...
Breaking Medicine Technology: